Skip to main content

FDA Approves Long-Awaited Cholesterol Drugs

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease.

Lead image for this article

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease. The drugs — which could benefit millions — are an alternative to the much-cheaper statins, the common cholesterol-lowering drug that might not be adequate for some. (Wall Street Journal

Quality journalism doesn't come free

Yes, I'll donate today